Selected research
Market Structure
Global Nuclear Medicine Software Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Nuclear Medicine Software market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The US & Canada market for Nuclear Medicine Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Nuclear Medicine Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Nuclear Medicine Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Nuclear Medicine Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Nuclear Medicine Software include iQ IMAGE, Mediso, Segami, Hermes Medical Solutions, MIM Software Inc, LabLogic, scintido, Gamma Gurus and Mirion Medical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Includes
This report provides an overview of the global Nuclear Medicine Software market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Nuclear Medicine Software and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Nuclear Medicine Software revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Nuclear Medicine Software market size, projected growth trends, production technologies, key applications, and end-use industries.
Nuclear Medicine Software Segment by Company
iQ IMAGE
Mediso
Segami
Hermes Medical Solutions
MIM Software Inc
LabLogic
scintido
Gamma Gurus
Mirion Medical
PAIRE
GE HealthCare
Inter Medical
Sirona
Nuclear Medicine Software Segment by Type
Drug Management
Radiation Management
Other
Nuclear Medicine Software Segment by Application
Clinical Diagnosis
Research
Others
Nuclear Medicine Software Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nuclear Medicine Software market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Nuclear Medicine Software and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nuclear Medicine Software.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Nuclear Medicine Software in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Nuclear Medicine Software industry.
Chapter 3: Detailed analysis of Nuclear Medicine Software companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Nuclear Medicine Softwarerevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Drug Management
- Radiation Management
- Other
Applications
- Clinical Diagnosis
- Research
- Others
Companies covered
- iQ IMAGE
- Mediso
- Segami
- Hermes Medical Solutions
- MIM Software Inc
- LabLogic
- scintido
- Gamma Gurus
- Mirion Medical
- PAIRE
- GE HealthCare
- Inter Medical
- Sirona
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global Nuclear Medicine Software Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
- 1.2.2 Drug Management
- 1.2.3 Radiation Management
- 1.2.4 Other
- 1.3 Market Analysis by Application
- 1.3.1 Global Nuclear Medicine Software Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
- 1.3.2 Clinical Diagnosis
- 1.3.3 Research
- 1.3.4 Others
- 1.4 Global Market Growth Prospects
- 1.5 Global Nuclear Medicine Software Growth Trends by Region
- 1.5.1 Global Nuclear Medicine Software Market Size by Region: 2021 VS 2025 VS 2032
- 1.5.2 Nuclear Medicine Software Market Size by Region (2021-2026)
- 1.5.3 Nuclear Medicine Software Market Size by Region (2027-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
2 Global Nuclear Medicine Software Market Dynamics
- 2.1 Nuclear Medicine Software Industry Trends
- 2.2 Nuclear Medicine Software Industry Drivers
- 2.3 Nuclear Medicine Software Industry Opportunities and Challenges
- 2.4 Nuclear Medicine Software Industry Restraints
3 Competitive Landscape by Company
- 3.1 Global Nuclear Medicine Software Revenue by Company (2021-2026)
- 3.2 Global Nuclear Medicine Software Players Revenue Ranking, 2024 VS 2025 VS 2026
- 3.3 Global Nuclear Medicine Software Key Company Head office and Area Served
- 3.4 Global Nuclear Medicine Software Company, Product Type & Application
- 3.5 Global Nuclear Medicine Software Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global Nuclear Medicine Software Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 Nuclear Medicine Software Players Market Share by Revenue in 2025
- 3.6.3 2025 Nuclear Medicine Software Tier 1, Tier 2, and Tier 3
4 Nuclear Medicine Software Market by Type
- 4.1 Global Nuclear Medicine Software Market Size by Type (2021 VS 2025 VS 2032)
- 4.2 Global Nuclear Medicine Software Market Size by Type (2021-2032)
- 4.3 Global Nuclear Medicine Software Market Size Share by Type (2021-2032)
5 Nuclear Medicine Software Market by Application
- 5.1 Global Nuclear Medicine Software Market Size by Application (2021 VS 2025 VS 2032)
- 5.2 Global Nuclear Medicine Software Market Size by Application (2021-2032)
- 5.3 Global Nuclear Medicine Software Market Size Share by Application (2021-2032)
6 Company Profiles
- 6.1 iQ IMAGE
- 6.1.1 iQ IMAGE Company Information
- 6.1.2 iQ IMAGE Business Overview
- 6.1.3 iQ IMAGE Nuclear Medicine Software Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.1.4 iQ IMAGE Nuclear Medicine Software Product Portfolio
- 6.1.5 iQ IMAGE Recent Developments
- 6.2 Mediso
- 6.2.1 Mediso Company Information
- 6.2.2 Mediso Business Overview
- 6.2.3 Mediso Nuclear Medicine Software Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.2.4 Mediso Nuclear Medicine Software Product Portfolio
- 6.2.5 Mediso Recent Developments
- 6.3 Segami
- 6.3.1 Segami Company Information
- 6.3.2 Segami Business Overview
- 6.3.3 Segami Nuclear Medicine Software Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.3.4 Segami Nuclear Medicine Software Product Portfolio
- 6.3.5 Segami Recent Developments
- 6.4 Hermes Medical Solutions
- 6.4.1 Hermes Medical Solutions Company Information
- 6.4.2 Hermes Medical Solutions Business Overview
- 6.4.3 Hermes Medical Solutions Nuclear Medicine Software Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.4.4 Hermes Medical Solutions Nuclear Medicine Software Product Portfolio
- 6.4.5 Hermes Medical Solutions Recent Developments
- 6.5 MIM Software Inc
- 6.5.1 MIM Software Inc Company Information
- 6.5.2 MIM Software Inc Business Overview
- 6.5.3 MIM Software Inc Nuclear Medicine Software Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.5.4 MIM Software Inc Nuclear Medicine Software Product Portfolio
- 6.5.5 MIM Software Inc Recent Developments
- 6.6 LabLogic
- 6.6.1 LabLogic Company Information
- 6.6.2 LabLogic Business Overview
- 6.6.3 LabLogic Nuclear Medicine Software Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.6.4 LabLogic Nuclear Medicine Software Product Portfolio
- 6.6.5 LabLogic Recent Developments
- 6.7 scintido
- 6.7.1 scintido Company Information
- 6.7.2 scintido Business Overview
- 6.7.3 scintido Nuclear Medicine Software Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.7.4 scintido Nuclear Medicine Software Product Portfolio
- 6.7.5 scintido Recent Developments
- 6.8 Gamma Gurus
- 6.8.1 Gamma Gurus Company Information
- 6.8.2 Gamma Gurus Business Overview
- 6.8.3 Gamma Gurus Nuclear Medicine Software Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.8.4 Gamma Gurus Nuclear Medicine Software Product Portfolio
- 6.8.5 Gamma Gurus Recent Developments
- 6.9 Mirion Medical
- 6.9.1 Mirion Medical Company Information
- 6.9.2 Mirion Medical Business Overview
- 6.9.3 Mirion Medical Nuclear Medicine Software Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.9.4 Mirion Medical Nuclear Medicine Software Product Portfolio
- 6.9.5 Mirion Medical Recent Developments
- 6.10 PAIRE
- 6.10.1 PAIRE Company Information
- 6.10.2 PAIRE Business Overview
- 6.10.3 PAIRE Nuclear Medicine Software Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.10.4 PAIRE Nuclear Medicine Software Product Portfolio
- 6.10.5 PAIRE Recent Developments
- 6.11 GE HealthCare
- 6.11.1 GE HealthCare Company Information
- 6.11.2 GE HealthCare Business Overview
- 6.11.3 GE HealthCare Nuclear Medicine Software Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.11.4 GE HealthCare Nuclear Medicine Software Product Portfolio
- 6.11.5 GE HealthCare Recent Developments
- 6.12 Inter Medical
- 6.12.1 Inter Medical Company Information
- 6.12.2 Inter Medical Business Overview
- 6.12.3 Inter Medical Nuclear Medicine Software Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.12.4 Inter Medical Nuclear Medicine Software Product Portfolio
- 6.12.5 Inter Medical Recent Developments
- 6.13 Sirona
- 6.13.1 Sirona Company Information
- 6.13.2 Sirona Business Overview
- 6.13.3 Sirona Nuclear Medicine Software Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.13.4 Sirona Nuclear Medicine Software Product Portfolio
- 6.13.5 Sirona Recent Developments
7 North America
- 7.1 North America Nuclear Medicine Software Market Size (2021-2032)
- 7.2 North America Nuclear Medicine Software Market Size by Type
- 7.2.1 North America Nuclear Medicine Software Market Size by Type (2021-2026)
- 7.2.2 North America Nuclear Medicine Software Market Size by Type (2027-2032)
- 7.2.3 North America Nuclear Medicine Software Market Share by Type (2021-2032)
- 7.3 North America Nuclear Medicine Software Market Size by Application
- 7.3.1 North America Nuclear Medicine Software Market Size by Application (2021-2026)
- 7.3.2 North America Nuclear Medicine Software Market Size by Application (2027-2032)
- 7.3.3 North America Nuclear Medicine Software Market Share by Application (2021-2032)
- 7.4 North America Nuclear Medicine Software Market Size by Country
- 7.4.1 North America Nuclear Medicine Software Market Size by Country (2021 VS 2025 VS 2032)
- 7.4.2 North America Nuclear Medicine Software Market Size by Country (2021-2026)
- 7.4.3 North America Nuclear Medicine Software Market Size by Country (2027-2032)
- 7.4.4 North America Nuclear Medicine Software Market Share by Country (2021-2032)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
8 Europe
- 8.1 Europe Nuclear Medicine Software Market Size (2021-2032)
- 8.2 Europe Nuclear Medicine Software Market Size by Type
- 8.2.1 Europe Nuclear Medicine Software Market Size by Type (2021-2026)
- 8.2.2 Europe Nuclear Medicine Software Market Size by Type (2027-2032)
- 8.2.3 Europe Nuclear Medicine Software Market Share by Type (2021-2032)
- 8.3 Europe Nuclear Medicine Software Market Size by Application
- 8.3.1 Europe Nuclear Medicine Software Market Size by Application (2021-2026)
- 8.3.2 Europe Nuclear Medicine Software Market Size by Application (2027-2032)
- 8.3.3 Europe Nuclear Medicine Software Market Share by Application (2021-2032)
- 8.4 Europe Nuclear Medicine Software Market Size by Country
- 8.4.1 Europe Nuclear Medicine Software Market Size by Country (2021 VS 2025 VS 2032)
- 8.4.2 Europe Nuclear Medicine Software Market Size by Country (2021-2026)
- 8.4.3 Europe Nuclear Medicine Software Market Size by Country (2027-2032)
- 8.4.4 Europe Nuclear Medicine Software Market Share by Country (2021-2032)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
9 China
- 9.1 China Nuclear Medicine Software Market Size (2021-2032)
- 9.2 China Nuclear Medicine Software Market Size by Type
- 9.2.1 China Nuclear Medicine Software Market Size by Type (2021-2026)
- 9.2.2 China Nuclear Medicine Software Market Size by Type (2027-2032)
- 9.2.3 China Nuclear Medicine Software Market Share by Type (2021-2032)
- 9.3 China Nuclear Medicine Software Market Size by Application
- 9.3.1 China Nuclear Medicine Software Market Size by Application (2021-2026)
- 9.3.2 China Nuclear Medicine Software Market Size by Application (2027-2032)
- 9.3.3 China Nuclear Medicine Software Market Share by Application (2021-2032)
10 Asia (Excluding China)
- 10.1 Asia Nuclear Medicine Software Market Size (2021-2032)
- 10.2 Asia Nuclear Medicine Software Market Size by Type
- 10.2.1 Asia Nuclear Medicine Software Market Size by Type (2021-2026)
- 10.2.2 Asia Nuclear Medicine Software Market Size by Type (2027-2032)
- 10.2.3 Asia Nuclear Medicine Software Market Share by Type (2021-2032)
- 10.3 Asia Nuclear Medicine Software Market Size by Application
- 10.3.1 Asia Nuclear Medicine Software Market Size by Application (2021-2026)
- 10.3.2 Asia Nuclear Medicine Software Market Size by Application (2027-2032)
- 10.3.3 Asia Nuclear Medicine Software Market Share by Application (2021-2032)
- 10.4 Asia Nuclear Medicine Software Market Size by Country
- 10.4.1 Asia Nuclear Medicine Software Market Size by Country (2021 VS 2025 VS 2032)
- 10.4.2 Asia Nuclear Medicine Software Market Size by Country (2021-2026)
- 10.4.3 Asia Nuclear Medicine Software Market Size by Country (2027-2032)
- 10.4.4 Asia Nuclear Medicine Software Market Share by Country (2021-2032)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa Nuclear Medicine Software Market Size (2021-2032)
- 11.2 South America, Middle East & Africa Nuclear Medicine Software Market Size by Type
- 11.2.1 South America, Middle East & Africa Nuclear Medicine Software Market Size by Type (2021-2026)
- 11.2.2 South America, Middle East & Africa Nuclear Medicine Software Market Size by Type (2027-2032)
- 11.2.3 South America, Middle East & Africa Nuclear Medicine Software Market Share by Type (2021-2032)
- 11.3 South America, Middle East & Africa Nuclear Medicine Software Market Size by Application
- 11.3.1 South America, Middle East & Africa Nuclear Medicine Software Market Size by Application (2021-2026)
- 11.3.2 South America, Middle East & Africa Nuclear Medicine Software Market Size by Application (2027-2032)
- 11.3.3 South America, Middle East & Africa Nuclear Medicine Software Market Share by Application (2021-2032)
- 11.4 South America, Middle East & Africa Nuclear Medicine Software Market Size by Country
- 11.4.1 South America, Middle East & Africa Nuclear Medicine Software Market Size by Country (2021 VS 2025 VS 2032)
- 11.4.2 South America, Middle East & Africa Nuclear Medicine Software Market Size by Country (2021-2026)
- 11.4.3 South America, Middle East & Africa Nuclear Medicine Software Market Size by Country (2027-2032)
- 11.4.4 South America, Middle East & Africa Nuclear Medicine Software Market Share by Country (2021-2032)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst